Novel therapies in breast cancer: what is new from ASCO 2008

被引:0
|
作者
David Chu
Janice Lu
机构
[1] State University of New York at Stony Brook,Division of Medical Oncology, Department of Medicine
关键词
Epidermal Growth Factor Receptor; Bevacizumab; Trastuzumab; Metastatic Breast Cancer; Sunitinib;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Novel therapies in breast cancer: what is new from ASCO 2008
    Chu, David
    Lu, Janice
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2008, 1 (1) : 16
  • [2] ASCO 2009: What's New in Breast Cancer Therapy?
    Biganzoli, Laura
    Bonnefoi, Herve
    Cardoso, Fatima
    Coleman, Robert
    Thuerlimann, Beat
    [J]. BREAST CARE, 2009, 4 (04) : 268 - 271
  • [3] News from ASCO 2015-What Was Relevant for Breast Cancer Experts?
    Huober, Jens
    Decker, Thomas
    Liedtke, Cornelia
    Marme, Frederik
    Marschner, Norbert
    Mueller, Volknnar
    [J]. BREAST CARE, 2015, 10 (04) : 285 - 288
  • [4] ASCO 2019: New Results in Breast Cancer
    Gluz, Oleg
    Hartkopf, Andreas
    Kuemmel, Sherko
    Marme, Frederik
    [J]. BREAST CARE, 2019, 14 (04) : 256 - 258
  • [5] Breast Cancer News from ASCO 2013
    Dall, Peter
    Liedtke, Cornelia
    Rack, Brigitte
    Schuetz, Florian
    Stickeler, Elmar
    [J]. BREAST CARE, 2013, 8 (04) : 307 - 309
  • [6] Highlights in breast cancer from ASCO 2016
    Cardoso, Fatima
    [J]. ESMO OPEN, 2016, 1 (05)
  • [7] Novel endocrine therapies in breast cancer
    Klijn, JGM
    SetyonoHan, B
    Bontenbal, M
    Seynaeve, C
    Foekens, J
    [J]. ACTA ONCOLOGICA, 1996, 35 (05) : 30 - 37
  • [8] Novel systemic therapies for breast cancer
    Lo, S
    Johnston, SRD
    [J]. SURGICAL ONCOLOGY-OXFORD, 2003, 12 (04): : 277 - 287
  • [9] Triple-negative breast cancer: new perspectives for novel therapies
    Yashin A. Mahamodhossen
    Wei Liu
    Zhou Rong-Rong
    [J]. Medical Oncology, 2013, 30
  • [10] Triple-negative breast cancer: Novel therapies and new directions
    Pal, Sumanta Kumar
    Mortimer, Joanne
    [J]. MATURITAS, 2009, 63 (04) : 269 - 274